Although not analyzed in this study due to the retrospective design and lower prevalence of Grave's disease in the pediatric population (0.04%) [11], anti-TSH receptor antibodies should also be considered, as they are also associated with ANA positivity [5,6], but are typically identified in patients that already have clinical signs and symptoms of hyperthyroidism. This evidence concerns the gene BTG3 and Graves disease.